NCT02282332View on ClinicalTrials.gov

NIRS Ticagrelor Evaluation

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Coronary Artery Disease

Interventions

DRUG

Ticagrelor

Sponsors

Lead Sponsor

Medstar Health Research Institute

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Medstar Health Research Institute

OTHER